Literature DB >> 12850306

No involvement of IgG autoantibodies against extracellular domains of desmoglein 2 in paraneoplastic pemphigus or inflammatory bowel diseases.

Takayuki Ota1, Masayuki Amagai, Mamoru Watanabe, Takeji Nishikawa.   

Abstract

BACKGROUND: Patients with paraneoplastic pemphigus (PNP) and inflammatory bowel diseases, such as Crohn's disease (CD) and ulcerative colitis (UC), develop autoantibodies against simple epithelial cells. About 20-30% of patients with PNP develop fatal bronchiolitis obliterans, in which autoantibody-mediated injury is suspected because of in vivo IgG deposition on cell surfaces of bronchial epithelia.
OBJECTIVE: The purpose of this study is to determine whether patients with PNP, CD and UC have IgG autoantibodies against desmoglein 2 (Dsg2), which is expressed in all desmosome-bearing cells including respiratory and intestinal epithelia.
METHODS: A secreted form of recombinant Dsg2 (rDsg2-His) which contains its entire extracellular domains was produced by baculovirus expression. The reactivity of patients' sera against rDsg2-His was examined by ELISA as well as immunoprecipitation.
RESULTS: An anti-Dsg2 mouse monoclonal antibody, 6D8, showed positive reactivity against rDsg2-His in both methods. However, none of 38 PNP sera reacted with rDsg2-His by ELISA and none of 15 PNP sera tested immunoprecipitated rDsg2-His. Furthermore, none of 12 CD or 27 UC sera reacted with rDsg2-His by ELISA.
CONCLUSION: These findings indicate that IgG autoantibodies against Dsg2 are not involved in PNP, CD or UC and suggest the existence of other unknown cell surface target antigen(s) in bronchiolitis obliterans in PNP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12850306     DOI: 10.1016/s0923-1811(03)00072-0

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  6 in total

1.  Pathogenic IgG4 autoantibodies from endemic pemphigus foliaceus recognize a desmoglein-1 conformational epitope.

Authors:  Flor Evangelista; Aleeza J Roth; Phillip Prisayanh; Brenda R Temple; Ning Li; Ye Qian; Donna A Culton; Zhi Liu; Oliver J Harrison; Julia Brasch; Barry Honig; Lawrence Shapiro; Luis A Diaz
Journal:  J Autoimmun       Date:  2018-01-04       Impact factor: 7.094

2.  Autoimmunity to desmocollin 3 in pemphigus vulgaris.

Authors:  Xuming Mao; Arielle R Nagler; Sara A Farber; Eun Jung Choi; Lauren H Jackson; Kristin M Leiferman; Norito Ishii; Takashi Hashimoto; Masayuki Amagai; John J Zone; Aimee S Payne
Journal:  Am J Pathol       Date:  2010-10-15       Impact factor: 4.307

3.  Divergent Specificity Development of IgG1 and IgG4 Autoantibodies in Endemic Pemphigus Foliaceus (Fogo Selvagem).

Authors:  Mike Maldonado; Luis A Diaz; Phillip Prisayanh; Jinsheng Yang; Bahjat F Qaqish; Valeria Aoki; Gunter Hans-Filho; Evandro A Rivitti; Donna A Culton; Ye Qian
Journal:  Immunohorizons       Date:  2017-08-01

4.  Desmoglein-2: a novel regulator of apoptosis in the intestinal epithelium.

Authors:  Porfirio Nava; Mike G Laukoetter; Ann M Hopkins; Oskar Laur; Kirsten Gerner-Smidt; Kathleen J Green; Charles A Parkos; Asma Nusrat
Journal:  Mol Biol Cell       Date:  2007-09-05       Impact factor: 4.138

5.  Defining the pathogenic involvement of desmoglein 4 in pemphigus and staphylococcal scalded skin syndrome.

Authors:  Takeshi Nagasaka; Koji Nishifuji; Takayuki Ota; Neil V Whittock; Masayuki Amagai
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

6.  Superficial dsg2 expression limits epidermal blister formation mediated by pemphigus foliaceus antibodies and exfoliative toxins.

Authors:  Donna Brennan; Ying Hu; Walid Medhat; Alicia Dowling; My G Mahoney
Journal:  Dermatol Res Pract       Date:  2010-06-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.